NuScriptRx Revenue and Competitors
Estimated Revenue & Valuation
- NuScriptRx's estimated annual revenue is currently $9.2M per year.
- NuScriptRx's estimated revenue per employee is $249,892
Employee Data
- NuScriptRx has 37 Employees.
- NuScriptRx grew their employee count by -5% last year.
NuScriptRx Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $134.5M | 455 | 21% | $28.5M | N/A |
#2 | $82.6M | 390 | 17% | N/A | N/A |
#3 | $58.1M | 228 | -2% | N/A | N/A |
#4 | $9.2M | 37 | -5% | N/A | N/A |
#5 | $18.3M | 98 | 36% | N/A | N/A |
#6 | $21.7M | 103 | 37% | $23.6M | N/A |
#7 | $2.3M | 22 | 0% | N/A | N/A |
#8 | $3M | 43 | 48% | N/A | N/A |
#9 | $3.8M | 40 | 8% | N/A | N/A |
#10 | $2.2M | 22 | 0% | N/A | N/A |
What Is NuScriptRx?
NuScriptRx Based in Nashville, Tenn., NuScriptRX is an institutional pharmacy that serves the pharmaceutical needs of long-term care facilities and their patients. Institutional long-term care pharmacy with: * A unique reduced cost of medication dispensing model - Highly automated robotic system for dispensing pharmaceuticals on a short cycle basis, providing medications in specialized unit dose patient packaging * Improved medication access - By providing localized remote dispensing through an integrated technology enabled system in each client's long-term care or rehab facility to improve medication access on a 24/7 basis * Higher quality assurance standards for patients - By enabling nurses to provide higher quality assurance / safety through our patient dosing system combined with an integrated medication management system (i.e. doses by medpass time with barcoding)
keywords:N/AN/A
Total Funding
37
Number of Employees
$9.2M
Revenue (est)
-5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $5.6M | 37 | 19% | N/A |
#2 | $9.7M | 37 | -3% | N/A |
#3 | $10.4M | 37 | -10% | N/A |
#4 | $7.6M | 37 | 3% | N/A |
#5 | $7.5M | 37 | 9% | N/A |